BSE filing, NSE: TGVSL. Summary written from the filing by ALFA Finder's alert engine.
TGV SRAAC Ltd: key numbers
- Share price
- ₹121.00
- Market cap
- ₹1,296 Cr
- Revenue (annual)
- ₹1,950 Cr
- Net profit (annual)
- ₹131.9 Cr
- P/E (TTM)
- 9.3×Sector 28.5×
- Promoter holding
- 64.41%+0.15% QoQ
- FII holding
- 0.17%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from TGV SRAAC Ltd
All →TGV SRAAC Q2 FY27 Results: Net Profit ₹55.7 Cr, Up 50.5% YoY
TGV SRAAC Ltd reported revenue from operations of ₹590.5 Cr (+18.1% YoY) and net profit of ₹55.7 Cr (+50.5% YoY) for Q2 FY27.
- Key figure
- Net profit ₹55.7 Cr · +50.5% YoY
TGV SRAAC Board Meeting Date
TGV Sraac will hold a board meeting on 11 November 2026 to consider unaudited financial results for the quarter and half year ended 30 September 2026. The trading window reopens on 13 November 2026.
TGV SRAAC Other Announcement
TGV Sraac Ltd filed its quarterly shareholding pattern for the period ended 30th September 2026, as required by SEBI Listing Regulations.
TGV SRAAC Other Announcement
TGV Sraac filed the monthly SEBI special-window report on re-lodgement of physical-share transfer requests for September 2026. The RTA report shows NIL requests, a routine compliance filing with no business impact.
TGV SRAAC Production Started
TGV Sraac Ltd has operationalized an additional 5.0 MWp solar power plant at its factory. This capacity addition is part of the company's broader renewable energy plans.
- solar capacity
- 5.0 MWp
TGV SRAAC Capacity Expansion
TGV SRAAC Limited added 5.00 MWp to its solar power capacity, increasing the total capacity from 65.40 MWp to 70.40 MWp.
- solar capacity
- 5.0 MWp
Other other announcement announcements
All →Bal Pharma Other Announcement
Bal Pharma filed a Reg 32 statement confirming no deviation in its ₹2.10 Cr preferential warrant proceeds, with nothing utilised by September 30, 2026. The amount remains fully unutilised.
- Value
- ₹2.10 Cr
Glottis Other Announcement
Glottis Limited filed its Reg 32 statement confirming no deviation in IPO fund utilisation for the quarter ended September 30, 2026. Gross proceeds of ₹15,999.87 Lakhs were raised, with ₹9,009.54 Lakhs utilised so far.
Lenskart Solutions Other Announcement
Lenskart filed a Reg 32 monitoring agency report on IPO proceeds for the quarter ended September 2026. Utilisation matches the prospectus with no deviations.
Manaksia Coated Metals & Industries Other Announcement
Manaksia Coated Metals filed its quarterly shareholding pattern, with promoters holding 51.93%. The filing is routine regulatory disclosure with no transaction or corporate event.
Network People Services Technologies Other Announcement
Network People Services Technologies reported a Reg 32 statement confirming no deviation in use of its Rs 300 Crore preferential allotment proceeds. Rs 56.52 Crore utilised by September 30, 2026, with the Audit Committee reviewing it.
Tata Power Company Other Announcement
Tata Power's auditor SRBC & Co issued a limited-assurance report confirming compliance with debenture trust deed covenants as at September 30, 2026. It is a routine Reg 56(1)(d) compliance certificate with no new money or business event.